We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SEC Probes Teva Over Possible FCPA Violations in Latin America
SEC Probes Teva Over Possible FCPA Violations in Latin America
August 10, 2012
Teva Pharmaceuticals is the target of an SEC bribery investigation and has been handed a subpoena for documents related to its compliance with the Foreign Corrupt Practice Act (FCPA) in Latin America.